| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 3 | 0 | 9 | 5 | 4 | 5 | 4 | 5 | 6 | 5 | 5 | 6 | 5 | 6 | 8 | 8 | 4 | 3 | 6 | 9 | 9 | 5 | 13 | 16 | 16 | 16 | 19 | 21 | 17 | 11 | 8 | 10 | 8 | 11 | 8 | 10 | 11 | 13 | 12 | 13 | 10 | 9 | 13 | 19 | 22 | 19 |
| Expenses | 3 | 0 | 7 | 4 | 4 | 4 | 3 | 4 | 4 | 5 | 4 | 5 | 4 | 5 | 6 | 6 | 5 | 5 | 6 | 6 | 14 | 5 | 7 | 8 | 11 | 10 | 12 | 14 | 14 | 9 | 8 | 9 | 9 | 8 | 8 | 9 | 10 | 10 | 9 | 10 | 10 | 11 | 10 | 14 | 17 | 15 |
| EBITDA | 1 | 0 | 2 | 1 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | -1 | -1 | 0 | 2 | -5 | 1 | 6 | 9 | 5 | 6 | 7 | 7 | 3 | 2 | -0 | 2 | -1 | 2 | 1 | 1 | 1 | 3 | 3 | 2 | -0 | -1 | 2 | 5 | 5 | 3 |
| Operating Profit % | 20 % | 0 % | 16 % | 19 % | -17 % | 16 % | 17 % | 17 % | 16 % | 9 % | 21 % | 21 % | 13 % | 22 % | 29 % | 32 % | -15 % | -42 % | -6 % | 23 % | -95 % | 15 % | 38 % | 53 % | 32 % | 36 % | 34 % | 32 % | -18 % | 12 % | -5 % | 15 % | -13 % | 20 % | 7 % | 10 % | 9 % | 25 % | 22 % | 17 % | -4 % | -20 % | 17 % | 27 % | 20 % | 16 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -2 | -3 | -2 | 1 | -7 | -1 | 4 | 7 | 4 | 5 | 5 | 6 | 2 | 0 | -2 | 0 | -3 | 1 | -1 | -1 | -1 | 2 | 1 | 0 | -3 | -4 | 0 | 3 | 3 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | -1 | -0 | 0 | -1 | -0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | -0 | -0 | 0 | -0 | 0 | -0 | -0 | 0 | 1 | 1 | 0 | -1 | -1 | 0 | 1 | 1 | 0 |
| Net Profit | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -0 | 0 | 1 | 1 | -2 | -2 | -1 | 0 | -6 | -1 | 3 | 6 | 4 | 3 | 4 | 4 | 1 | 0 | -1 | 0 | -2 | 1 | -1 | -1 | -1 | 1 | 0 | 0 | -1 | -3 | 0 | 2 | 2 | 1 |
| EPS in ₹ | 0.70 | 0.00 | 1.50 | 0.25 | -1.77 | 0.16 | 0.20 | 0.24 | 0.51 | 0.03 | 0.09 | 0.12 | -0.05 | 0.26 | 0.93 | 0.52 | -0.97 | -1.37 | -0.95 | 0.26 | -3.56 | -0.37 | 1.79 | 3.74 | 2.56 | 2.17 | 2.45 | 2.80 | 0.52 | 0.25 | -0.78 | 0.04 | -1.51 | 0.33 | -0.39 | -0.31 | -0.47 | 0.66 | 0.16 | 0.03 | -0.81 | -2.03 | 0.01 | 1.52 | 0.92 | 0.44 |
Jeevan Scientific Technology
Jeevan Scientific Technology
73.35
-0.83
(-1.12%)
Market Cap
147.33 Cr
PE Ratio
29.09
Volume
17,105.00
Day High - Low
76.00 - 72.60
52W High-Low
93.90 - 32.85
Key Fundamentals
Market Cap
147.33 Cr
EPS
0.52
PE Ratio
29.09
PB Ratio
2.07
Book Value
35.91
EBITDA
9.80
Dividend Yield
0.00 %
Industry
Healthcare Sector
Healthcare Technology Return on Equity
0.12
Debt to Equity
0.35
Actual
Company News
View All News
Jeevan Scientific Technology reported a standalone net profit of ₹188.60 lakh for Q1FY27, up 87.5% YoY. The board also approved director appointments and the AGM date.
Jeevan Scientific Technology Ltd secured CDSCO approval to expand its BA/BE Study Centre in Hyderabad. The facility will increase bed capacity from 132 to 156, boosting clinical research output.
Jeevan Scientific FY26 profit rises 124%
May 29, 2026
May 29, 2026Jeevan Scientific Technology reported a consolidated net profit of ₹103.33 lakh for FY26, a 1651% increase from ₹5.90 lakh in FY25. Revenue from operations rose to ₹6,153.71 lakh.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
407.25 | #1 16,439.43 | 72.28 | #1 3,809.40 | 2.56 | 317 | -110.38 | 49.59 | |
567.80 | 13,681.39 | 34.02 | 3,582.50 | 21.58 | #1 401 | -0.17 | 64.15 | |
373.15 | 9,840.73 | -30.03 | 21.00 | 19.32 | -276 | -147.77 | 65.90 | |
629.65 | 2,812.61 | 35.09 | 322.30 | 0.22 | 41 | 112.87 | 55.95 | |
20.83 | 308.15 | #1 25.41 | 54.19 | #1 431.27 | 11 | 222.22 | 33.48 | |
93.66 | 220.52 | -35.55 | 733.54 | -9.05 | -21 | #1 253.06 | 70.91 | |
73.35 | #7 147.33 | #2 29.09 | #5 61.54 | #2 29.56 | #5 2 | #3 128.13 | 42.98 | |
17.50 | 25.30 | 33.09 | 56.10 | -33.21 | 1 | -83.33 | 22.50 | |
19.64 | 14.00 | 130.93 | 1.82 | -13.33 | 0 | -380.00 | 13.81 |
Growth Rate
Revenue Growth
29.56 %
Net Income Growth
1,880.00 %
Cash Flow Change
248.44 %
ROE
-104.40 %
ROCE
-353.70 %
EBITDA Margin (Avg.)
-7.66 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 | 107 |
| Fixed Assets | 9 | 16 | 28 | 33 | 31 | 27 | 19 | 25 | 27 | 35 | 41 |
| Current Assets | 11 | 14 | 21 | 25 | 18 | 34 | 54 | 29 | 25 | 29 | 50 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 5 | 5 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Assets | 12 | 15 | 21 | 29 | 23 | 39 | 59 | 39 | 38 | 39 | 0 |
| Total Equity & Liabilities | 20 | 31 | 49 | 61 | 54 | 66 | 78 | 66 | 68 | 78 | 107 |
| Current Liabilities | 8 | 9 | 17 | 21 | 23 | 23 | 22 | 11 | 9 | 12 | 20 |
| Non Current Liabilities | 8 | 5 | 10 | 8 | 8 | 8 | 5 | 6 | 10 | 16 | 14 |
| Total Equity | 4 | 17 | 22 | 32 | 23 | 35 | 51 | 48 | 49 | 50 | 72 |
| Reserve & Surplus | -2 | 3 | 7 | 17 | 8 | 20 | 35 | 33 | 33 | 34 | 52 |
| Share Capital | 6 | 9 | 12 | 15 | 15 | 15 | 15 | 16 | 16 | 16 | 20 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 1 | 2 | -2 | 4 | 24 | -23 | -6 | -0 |
| Investing Activities | -4 | -9 | -14 | -8 | -2 | -1 | -1 | -7 | -12 | -16 |
| Operating Activities | 4 | -6 | 6 | 4 | 0 | 5 | 20 | -6 | 3 | 10 |
| Financing Activities | 0 | 15 | 10 | 6 | 0 | -0 | 6 | -10 | 2 | 5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 38.11 % | 38.11 % | 38.11 % | 38.11 % | 36.15 % | 36.47 % | 36.47 % | 36.85 % | 38.44 % | 38.48 % | 38.48 % | 38.48 % | 38.70 % | 38.70 % | 38.70 % | 37.84 % | 38.05 % | 38.05 % | 38.05 % | 38.05 % | 30.25 % | 30.25 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 48.08 % | 45.99 % | 46.82 % | 46.70 % | 48.56 % | 48.38 % | 44.89 % | 44.65 % | 42.87 % | 42.89 % | 45.98 % | 45.51 % | 45.50 % | 45.34 % | 45.75 % | 45.91 % | 42.99 % | 42.75 % | 42.76 % | 46.56 % | 55.79 % | 55.80 % |
| Others | 13.81 % | 15.90 % | 15.06 % | 15.18 % | 15.29 % | 15.15 % | 18.64 % | 18.50 % | 18.69 % | 18.63 % | 15.53 % | 16.00 % | 15.80 % | 15.96 % | 15.55 % | 16.25 % | 18.96 % | 19.21 % | 19.19 % | 15.39 % | 13.96 % | 13.95 % |
| No of Share Holders | 2,740 | 3,999 | 5,499 | 5,813 | 6,144 | 6,439 | 6,449 | 6,295 | 6,061 | 5,911 | 5,933 | 5,727 | 5,749 | 5,655 | 5,607 | 5,565 | 5,497 | 5,460 | 5,444 | 5,159 | 5,053 | 4,966 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.5 | 1.2 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.38 | 2.38 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2021 |  Dividend | ₹ 0.50 /share | 07 Sept 2021 | 98.10 | 96.40 |
| 23 Sept 2022 | Dividend | ₹ 1.20 /share | 21 Sept 2022 | 83.05 | 66.35 |
| 09 Aug 2024 |  Annual General Meeting | NA | 09 Aug 2024 | 50.73 | 56.59 |
| 08 Nov 2024 |  Quarterly Result Announcement | NA | 08 Nov 2024 | 52.94 | 52.88 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 45.04 | 45.23 |
| 27 Mar 2025 |  Extraordinary General Meeting | NA | 27 Mar 2025 | 43.01 | 41.38 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 41.03 | 40.32 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 39.36 | 42.31 |
| 27 Sept 2025 | Annual General Meeting | NA | 27 Sept 2025 | 38.41 | 35.00 |
| 12 Nov 2025 | Extraordinary General Meeting | NA | 12 Nov 2025 | 55.77 | 60.05 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 62.83 | 60.05 |
| 11 Feb 2026 | Quarterly Result Announcement | NA | 11 Feb 2026 | 69.25 | 69.25 |
| 29 May 2026 | Quarterly Result Announcement | NA | 29 May 2026 | 82.80 | 84.36 |
| 13 Aug 2026 | Quarterly Result Announcement | NA | 13 Aug 2026 | 80.45 | 78.52 |
Announcements
Statement On Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20158 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Change in Management8 days ago
8 days agoUnaudited Financial Results (Standalone And Consoilidated) For The Quarter Ended 30.06.2026.8 days ago
8 days agoBoard Meeting Outcome for Outcome Of The Board Meeting8 days ago
8 days agoBoard Meeting Intimation for Intimation Of Board Meeting To Be Held On 13.08.2026.10 days ago
10 days agoIntimation Of Approval For Addition Of Beds To The Existing Approved Bioavailability/ Bioequivalence Center Of Jeevan Scientific Technology Limiteds Bioavailability/Bioequivalence.Aug 01, 2026
Aug 01, 2026Information About The Successful Completion Of USFDA Inspection.Jul 24, 2026
Jul 24, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 16, 2026
Jul 16, 2026Notification Of Inspection For Addition Of Beds To The Existing Approved Bioavailability/Bioequivalence Center Of Jeevan Scientific Technology Limited.Jun 25, 2026
Jun 25, 2026Closure of Trading WindowJun 25, 2026
Jun 25, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Statement Of Deviation Or Variation Of FundsMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2026
May 29, 2026Audited Financial Results For The Quarter And Year Ended 31.03.2026May 29, 2026
May 29, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 29.05.2026May 29, 2026
May 29, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 29-05-2026May 21, 2026
May 21, 2026Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 30, 2026
Apr 30, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Apr 30, 2026Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 30, 2026
Apr 30, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Apr 30, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Apr 14, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 30, 2026
Mar 30, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 30, 2026
Mar 30, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Unaudited Financial Results For The Quarter Ended 31-12-2025.Feb 11, 2026
Feb 11, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 11-02-2026Feb 11, 2026
Feb 11, 2026Closure Of The United States Food And Drug Administration (US FDA) Remote Regulatory Assessment Of JSTL And Issuance Of The Remote Regulatory Assessment Report - Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 22, 2026
Jan 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 07, 2026
Jan 07, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 07, 2026
Jan 07, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Jan 06, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On 02.01.2026Jan 02, 2026
Jan 02, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Dec 31, 2025Update on board meetingDec 29, 2025
Dec 29, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30-12-2025.Dec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 18, 2025
Dec 18, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationNov 12, 2025
Nov 12, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 12, 2025
Nov 12, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMNov 12, 2025
Nov 12, 2025Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025Nov 12, 2025
Nov 12, 2025Technical Indicators
RSI(14)
Neutral 44.55
ATR(14)
Volatile 4.99
STOCH(9,6)
Neutral 29.69
STOCH RSI(14)
Oversold 14.94
MACD(12,26)
Bearish -0.37
ADX(14)
Weak Trend 22.11
UO(9)
Bearish 33.27
ROC(12)
Downtrend And Accelerating -3.71
WillR(14)
Oversold -82.65
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
